E Fund Management (HK)’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4K Buy
113
+30
+36% +$4.6K 0.01% 344
2026
Q1
$13.2K Buy
+83
New +$14K 0.01% 300

Other funds holding BLTE

E Fund Management (HK)'s BLTE Position: Q2 2026 in Review

E Fund Management (HK) increased its Belite Bio (BLTE) stake by 36% in Q2 2026, buying an estimated $4.6K and bringing the position to 113 shares worth $17.4K. The position accounts for 0.01% of the portfolio, ranked #344.

E Fund Management (HK) first reported a position in BLTE in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • E Fund Management (HK) held 113 shares of Belite Bio worth $17.4K as of Q2 2026.
  • E Fund Management (HK) bought 30 Belite Bio shares in Q2 2026, an estimated $4.6K.
  • Belite Bio made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #344 holding.
  • E Fund Management (HK) first reported a position in Belite Bio in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.